Ambiq Micro, Inc. (AMBQ) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates strong financial performance with increased sales and gross profit, despite a net loss. Management expressed confidence in future revenue growth, projecting over $100 million in 2026, supported by new technologies and product lines. While there are concerns about rising operational expenses and potential margin pressures, the optimistic guidance and strategic repositioning are positive indicators. The Q&A section reinforced this outlook with discussions on technological advantages and market expansion. Overall, these factors suggest a likely positive stock price movement, although the lack of market cap data limits precise impact assessment.
Key Financial Performance
Net Sales (4Q 2025) $20.7 million, increased 2% year-over-year. Reasons: Accelerating demand trends, strong end-user demand, broader adoption of Ambiq solutions, and customers upgrading to Apollo5.
Non-GAAP Gross Profit (4Q 2025) $9.4 million, increased 75.5% year-over-year. Reasons: Strategic repositioning, favorable product mix, and higher sales to customers deploying multiple edge AI capabilities.
Non-GAAP Gross Margin (4Q 2025) 45.5%, expanded almost 20 percentage points year-over-year. Reasons: Favorable product mix and strategic repositioning.
Non-GAAP R&D Expense (4Q 2025) $9.3 million, up 33% year-over-year. Reasons: Additional investment to support product development for Atomiq and Apollo families.
Non-GAAP SG&A Expense (4Q 2025) $7.3 million, up 19.7% year-over-year. Reasons: Public company costs, strategic investments in sales and marketing, and higher incentive compensation.
Other Income (4Q 2025) $1.3 million, up $1.1 million year-over-year. Reasons: Interest income earned on IPO proceeds.
Non-GAAP Net Loss Attributable to Common Stockholders (4Q 2025) $5.9 million, a $1.7 million improvement year-over-year. Reasons: Improved gross profit and strategic repositioning.
Full Year 2025 Gross Profit Increased 32.1% year-over-year despite a 4.7% decrease in net sales. Reasons: Strategic repositioning and stronger margins.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Apollo510 Lite, Apollo510B, Apollo330: Launched to support advanced edge AI applications.
HeliaAOT and HeliaRT: Introduced as AI runtime powered by Helia Core AI kernel library.
Atomiq: Announced as the first SPOT family built on a FinFET process, enabling operation down to 300 millivolts for ultra-low power and sophisticated AI capabilities.
Apollo340 and Atomiq120: Development accelerated to expand into new high-opportunity segments and support advanced AI workloads.
Wearables: Expanded into new form factors like rings and eyewear, broadening the addressable market.
Medical, Industrial, and Smart Home: Expanded customer base and design funnel, with applications in cardiac monitors, senior care devices, predictive maintenance, and energy optimization.
RONDS Partnership: Collaborated to deploy large-scale, always-on battery-powered sensors for industrial edge applications.
IPO and Follow-on Offering: Completed IPO and follow-on offering, raising $140.3 million and $76.8 million respectively, strengthening cash position for growth initiatives.
Strategic Repositioning: Shifted focus to high-value customers and reduced exposure to Mainland China, improving gross profit and margins.
R&D and SG&A Investments: Increased R&D and SG&A expenses to support product development and strategic growth priorities.
Edge AI Adoption: Focused on enabling advanced edge AI capabilities across diverse markets, leveraging SPOT platform.
Product Roadmap Acceleration: Accelerated development of Apollo and Atomiq families to capture market opportunities.
Market Diversification: Targeted expansion into high-value markets like medical, industrial, and smart home sectors.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory and Industrial Design Cycles: Longer design cycles in regulated and industrial environments could delay product adoption and revenue realization.
Supply Chain Pressures: Potential broader industry cost dynamics and supply chain pressures may impact gross margins.
Increased Operating Expenses: Non-GAAP operating expenses are expected to rise by approximately $30 million in 2026, driven by accelerated product development and IP purchases, which could strain financials.
Dependence on New Product Launches: The company's growth heavily relies on the successful launch and adoption of new products like Atomiq and Apollo families.
Customer Concentration Risk: A significant portion of revenue is tied to a few large customers, increasing vulnerability to changes in their demand or business strategies.
Market Competition: Intensifying competition in the edge AI market could pressure pricing and market share.
Economic Uncertainty: Broader economic uncertainties could impact customer spending and demand for edge AI solutions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
2026 Revenue Growth: Ambiq expects significant top-line growth in 2026, driven by new model launches, ramping up of a scaled global customer, higher volumes from recent customer introductions, and continued adoption of Apollo5.
Product Development and Launches: The company is accelerating development of both Atomiq and Apollo product families, with plans to start development of Apollo340 and Atomiq120 in 2026. These products are designed to expand into new high-opportunity segments and support advanced AI capabilities.
Market Trends and Expansion: Edge AI adoption is expected to accelerate in 2026, with increasing demand for sophisticated edge AI capabilities in wearables, medical devices, industrial markets, and smart homes. Wearables are evolving into personal health platforms, and new form factors like rings and eyewear are broadening the addressable market.
Financial Guidance for Q1 2026: Net sales are expected to range between $21 million and $22 million. Non-GAAP gross margin is projected between 44% and 45%. Non-GAAP operating expenses are estimated at $18 million to $18.5 million, reflecting increased investment in strategic growth priorities.
Long-Term Growth Drivers: Ambiq is investing in R&D, software, and go-to-market initiatives to capture a larger share of the expanding edge AI market. The Atomiq product family is expected to contribute meaningfully to growth starting in 2028.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide guidance on your strong outlook for 2026, including revenue expectations and quarter-to-quarter revenue patterns?
A:The CEO mentioned that Q4 is seen as an inflection point with strong customer forecasts. They expect Q1, Q2, and Q3 to be extremely strong, with Q4 typically peaking due to seasonality. They are confident in achieving more than $100 million in revenue, surpassing their original forecast.
Q:How does the 12-nanometer SPOT technology compare to standard low-voltage processes at TSMC in terms of operating voltage and power advantage?
A:The CTO explained that standard operating voltage at 12-nanometers is around 700 millivolts, while their SPOT technology operates at 300 millivolts, providing a fourfold energy advantage. Additional innovations in clock trees, bus fabrics, and memories could further enhance this advantage.
Q:What applications or end markets will drive strong growth in 2026, especially beyond wearables?
A:The CEO stated that while wearables remain a major contributor, 25% of their funnel now includes non-wearables such as industrial and medical applications. They expect a higher share of revenue from non-wearables in 2026, with strong growth across all product lines.
Q:Can you provide more details on the volatility in OpEx for 2026 and its distribution across the year?
A:The CFO outlined a $30 million year-over-year increase in OpEx, driven by hiring more engineering staff, contract engineering for project-based work, and IP acquisition for new products. Spending will be higher in Q2 and Q3 due to project timelines.
Q:Are you seeing any impact on demand due to elevated component pricing, and how will gross margins evolve in 2026?
A:The CFO noted that while they achieved a 45% gross margin in 2025, rising costs in the semiconductor industry could pressure margins in 2026. They focus on maximizing ASPs and improving yields but are monitoring industry dynamics closely.
Q:What is the timing and expected size of the ramp for the new customer in 2026?
A:The CEO mentioned that the new customer will start ramping in Q1 2026 with strong growth quarter-over-quarter, and they expect even bigger contributions in 2027.
Q:What percentage of revenue did Apollo5 contribute in 2025, and what is its expected contribution in 2026?
A:The CEO noted that Apollo5 adoption is increasing, but they did not provide specific percentages. They mentioned that all product lines, including Apollo3, 4, and 5, are growing, with Apollo5 showing fast growth in quantity.
Q:Review of Unclear Management Responses
A:Management avoided providing specific percentages for Apollo5's revenue contribution and used vague language when discussing its growth relative to other product lines.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Ambiq
Atomiq
Fumi
IP purchase
IPO
Investor Relations
Marketing
RONDS
SPOT platform
adoption
application
battery
cost
customer
derivative
design
development Apollo
device
edge capability
end market
expansion
expense
feature
form factor
health
improvement
investment
maintenance
model
portfolio
power
product family
reach
repositioning
sale
software
solution
term opportunity
wearable
AMBQ Transcript
Ambiq Micro, Inc. (AMBQ) Q1 2026 Earnings Call Transcript
Positive5-12
The earnings call reveals strong financial performance, with a 56.2% increase in gross profit and significant investment in product development. Despite a slight decline in gross margin due to a nonrecurring credit, the overall financial health is stable with $204.5 million in cash and no debt. The Q&A highlights promising growth in non-wearable markets and potential profitability by 2027-2028. Although there are concerns about gross margins, the company's strategic pricing and strong customer demand indicate a positive outlook. The lack of a market cap suggests a small-cap stock, likely leading to a more pronounced positive reaction.
Ambiq Micro, Inc. (AMBQ) Q4 2025 Earnings Call Transcript
Positive3-5
The earnings call indicates strong financial performance with increased sales and gross profit, despite a net loss. Management expressed confidence in future revenue growth, projecting over $100 million in 2026, supported by new technologies and product lines. While there are concerns about rising operational expenses and potential margin pressures, the optimistic guidance and strategic repositioning are positive indicators. The Q&A section reinforced this outlook with discussions on technological advantages and market expansion. Overall, these factors suggest a likely positive stock price movement, although the lack of market cap data limits precise impact assessment.
Major Drilling Group International Inc. (MDI:CA) Q1 2026 Earnings Call Transcript
Unknown9-9
The earnings call reveals several negative factors: decreased margins, increased costs, and a decline in net earnings. The Q&A highlights uncertainties in North America and lack of clarity on growth potential. Despite some growth prospects in South America, the lack of positive guidance and weak performance in the U.S. contribute to a negative sentiment. Additionally, the management's evasive responses to critical questions further undermine confidence.
Ambiq Micro, Inc. (AMBQ) Q2 2025 Earnings Call Transcript
Unknown9-9
The earnings call presented mixed signals: a strategic shift away from China led to reduced sales there, but overall revenue increased sequentially. Gross profit improved YoY, but operating expenses rose sequentially. The Q&A revealed optimism about edge AI growth and a stable gross margin outlook, yet management's vague responses on key metrics and timelines dampened sentiment. Despite some positive financial metrics, the lack of clear guidance and ongoing losses suggest a neutral stock price movement over the next two weeks.
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
